Search research articles
Contact Us
Filters
Showing results (61-70 of 129) with videos related to
Page
of 13
Sort By:
Brain Communications
|
March 2, 2026
Plasmalogen deficiency and the Alzheimer's disease risk of apolipoprotein E4
Jenny Hällqvist, Jan-Willem Taanman, Andreas Göteson, et al.
Journal of Medical Genetics
|
September 15, 2019
Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease
Ivan D Doykov, Wendy E Heywood, Valeria Nikolaenko, et al.
Molecular Neurodegeneration
|
January 13, 2016
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Amanda Heslegrave, Wendy Heywood, Ross Paterson, et al.
BMC Nephrology
|
August 15, 2020
Nail-patella-like renal disease masquerading as Fabry disease on kidney biopsy: a case report
Filippo Pinto E Vairo, Pavel N Pichurin, Fernando C Fervenza, et al.
Scientific Reports
|
March 17, 2017
Comparison of proteomic profiles in the zebrafish retina during experimental degeneration and regeneration
Karen Eastlake, Wendy E Heywood, Dhani Tracey-White, et al.
Biochimie
|
March 1, 2016
Formate supplementation enhances folate-dependent nucleotide biosynthesis and prevents spina bifida in a mouse model of folic acid-resistant neural tube defects
Sonia Sudiwala, Sandra C P De Castro, Kit-Yi Leung, et al.
Proteomics
|
March 23, 2006
Diagnosis of congenital disorders of glycosylation type-I using protein chip technology
Kevin Mills, Philippa Mills, Marie Jackson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2016
A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin
Kerri J Kinghorn, Sebastian Grönke, Jorge Iván Castillo-Quan, et al.
F1000Research
|
February 3, 2022
Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment
Katharina Iwan, Nina Patel, Amanda Heslegrave, et al.
Journal of Pediatric Surgery
|
June 21, 2011
Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors
Giuseppe Retrosi, Neil J Sebire, Mark Bishay, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 129) with videos related to
Sort By:
Page
of 13
Brain Communications
|
March 2, 2026
Plasmalogen deficiency and the Alzheimer's disease risk of apolipoprotein E4
Jenny Hällqvist, Jan-Willem Taanman, Andreas Göteson, et al.
Journal of Medical Genetics
|
September 15, 2019
Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease
Ivan D Doykov, Wendy E Heywood, Valeria Nikolaenko, et al.
Molecular Neurodegeneration
|
January 13, 2016
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Amanda Heslegrave, Wendy Heywood, Ross Paterson, et al.
BMC Nephrology
|
August 15, 2020
Nail-patella-like renal disease masquerading as Fabry disease on kidney biopsy: a case report
Filippo Pinto E Vairo, Pavel N Pichurin, Fernando C Fervenza, et al.
Scientific Reports
|
March 17, 2017
Comparison of proteomic profiles in the zebrafish retina during experimental degeneration and regeneration
Karen Eastlake, Wendy E Heywood, Dhani Tracey-White, et al.
Biochimie
|
March 1, 2016
Formate supplementation enhances folate-dependent nucleotide biosynthesis and prevents spina bifida in a mouse model of folic acid-resistant neural tube defects
Sonia Sudiwala, Sandra C P De Castro, Kit-Yi Leung, et al.
Proteomics
|
March 23, 2006
Diagnosis of congenital disorders of glycosylation type-I using protein chip technology
Kevin Mills, Philippa Mills, Marie Jackson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2016
A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin
Kerri J Kinghorn, Sebastian Grönke, Jorge Iván Castillo-Quan, et al.
F1000Research
|
February 3, 2022
Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment
Katharina Iwan, Nina Patel, Amanda Heslegrave, et al.
Journal of Pediatric Surgery
|
June 21, 2011
Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors
Giuseppe Retrosi, Neil J Sebire, Mark Bishay, et al.
Page
of 13